loader
Please Wait
Applying Filters...
Scorr-Insert
X

Information, Expiry & Status of FDA Orange Book Patents covering Ambrisentan

Client Email Product
Left Arrow
Right Arrow
Filters Filter
×
FILTER DATA :

filter

GILEAD

filter

8377933

9474752

9549926

filter

Blank

filter

Blank

filter

2027-12-11

2031-10-14

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

8377933
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
2

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

8377933
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
1

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

9474752
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
1

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

9474752
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
2

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

9549926
2031-10-14
U-1965
22081
1

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

9549926
2031-10-14
U-1965
22081
2

PharmaCompass >>

First
Previous
Next
Last